Nasdaq
$31.00▼ 0.63%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.88BShares out 1.300M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
28- 4d agoAfter-hours26.10.21 05:53144Ownership#●●●#●●●
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics insider Larry Todd Edwards has filed SEC Form 144 to report a proposed sale of company securities. This is a standard filing disclosing an insider's plan to dispose of shares.…more
$31.00-0.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoAfter-hours26.10.20 05:494Ownership
Arcutis Biotherapeutics, Inc.
Insider Howard G. Welgus of Arcutis Biotherapeutics, Inc. filed a Form 4 report regarding a change in beneficial ownership of securities effective October 15, 2026.…more
$31.00-0.63%vs prev closeView filingShare - 10.15Regular26.10.16 04:56144Ownership
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics insider Howard G. Welgus has filed a Form 144 to report the proposed sale of company shares. This is a standard regulatory filing disclosing an insider's plan to dispose of stock.…more
$31.00-0.63%vs prev closeView filingShare
27 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoAfter-hours26.10.22 05:00#●●●#●●●
Arcutis Biotherapeutics to Report Q3 2026 Financial Results on Nov 4
Arcutis Biotherapeutics announced that it will report its third quarter 2026 financial results after the market close on November 4, 2026. The company will also provide a business update during the scheduled conference call.…more
$31.00-0.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.9Pre-market26.10.09 21:00
●●●●●●●● ●●●●● ●●●●●●
Arcutis presented new clinical trial data for ZORYVE in infants and real-world research highlighting the limitations of topical corticosteroids. The findings aim to support the efficacy of ZORYVE across various chronic inflammatory skin conditions.…more
$31.00-0.63%vs prev close - 10.6Pre-market26.10.06 21:19
●●●●●●●● ●●●●● ●●●●●●
Arcutis Biotherapeutics announced that its ZORYVE cream received the 2026 Marie Claire Beauty Award for Best Prescription Skin Solution. While this highlights the product's market recognition, it does not represent a direct change in the company's financial performance.…more
$31.00-0.63%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report